UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 34

Sortiert nach

A role for TREX components in the release of spliced mRNA from nuclear speckle domains

Nature communications, 2010-10, Vol.1 (7), p.97-97, Article 97

2010

Link zum Volltext

Verfügbarkeit prüfen

Human mRNA Export Machinery Recruited to the 5′ End of mRNA

Cell, 2006-12, Vol.127 (7), p.1389-1400

2006

Link zum Volltext

Verfügbarkeit prüfen

ATP is required for interactions between UAP56 and two conserved mRNA export proteins, Aly and CIP29, to assemble the TREX complex

Genes & development, 2010-09, Vol.24 (18), p.2043-2053

2010

Link zum Volltext

Verfügbarkeit prüfen

GBT440 reverses sickling of sickled red blood cells under hypoxic conditions in vitro

Hematology reports, 2018-05, Vol.10 (2), p.7419-7419

2018

Link zum Volltext

Verfügbarkeit prüfen

Discovery of GBT440, an Orally Bioavailable R‑State Stabilizer of Sickle Cell Hemoglobin

ACS medicinal chemistry letters, 2017-03, Vol.8 (3), p.321-326

2017

Link zum Volltext

Verfügbarkeit prüfen

The proteins PDIP3 and ZC11A associate with the human TREX complex in an ATP-dependent manner and function in mRNA export

PloS one, 2012-08, Vol.7 (8), p.e43804-e43804

2012

Link zum Volltext

Verfügbarkeit prüfen

Functional coupling of RNAP II transcription to spliceosome assembly

Genes & development, 2006-05, Vol.20 (9), p.1100-1109

2006

Link zum Volltext

Verfügbarkeit prüfen

GBT440 Inhibits Sickling of Sickle Cell Trait Blood Under In Vitro Conditions Mimicking Strenuous Exercise

Hematology reports, 2016-09, Vol.8 (3), p.6637-6637

2016

Link zum Volltext

Verfügbarkeit prüfen

The effect of the antisickling compound GBT1118 on the permeability of red blood cells from patients with sickle cell anemia

Physiological reports, 2019-03, Vol.7 (6), p.e14027-n/a

2019

Link zum Volltext

Verfügbarkeit prüfen

GBT440 improves red blood cell deformability and reduces viscosity of sickle cell blood under deoxygenated conditions

Clinical hemorheology and microcirculation, 2018-01, Vol.70 (1), p.95

2018

Link zum Volltext

Verfügbarkeit prüfen

GBT021601 Prevents Microvascular Dysfunction and Improves Hypoxia-Reoxygenation-Induced Vaso-Occlusion in a Murine Model of Sickle Cell Disease

Blood, 2022-11, Vol.140 (Supplement 1), p.5377-5378

2022

Link zum Volltext

Verfügbarkeit prüfen

Increased Hemoglobin Affinity for Oxygen with GBT021601 Reduces Pulmonary Hypertension and Lung Vascular Inflammation in a Murine Model of Sickle Cell Disease

Blood, 2022-11, Vol.140 (Supplement 1), p.5375-5376

2022

Link zum Volltext

Verfügbarkeit prüfen

GBT440 increases haemoglobin oxygen affinity, reduces sickling and prolongs RBC half‐life in a murine model of sickle cell disease

British journal of haematology, 2016-10, Vol.175 (1), p.141-153

2016

Link zum Volltext

Verfügbarkeit prüfen

GBT021601 Increases Hemoglobin and Improves Red Blood Cell Deformability without Rebound Hyperviscosity upon Drug Clearance in a Sickle Mouse Model

Blood, 2022-11, Vol.140 (Supplement 1), p.5393-5394

2022

Link zum Volltext

Verfügbarkeit prüfen

A phase 1/2 ascending dose study and open-label extension study of voxelotor in patients with sickle cell disease

Blood, 2019-04, Vol.133 (17), p.1865-1875

2019

Link zum Volltext

Verfügbarkeit prüfen

Pharmacodynamic Results from Phase 1 Studies of GBT021601, a Next-Generation HbS Polymerization Inhibitor for Treatment of Sickle Cell Disease

Blood, 2022-11, Vol.140 (Supplement 1), p.24-25

2022

Link zum Volltext

Verfügbarkeit prüfen

GBT021601 Inhibits HbS Polymerization, Prevents RBC Sickling and Improves the Pathophysiology of Sickle Cell Disease in a Murine Model

Blood, 2020-11, Vol.136 (Supplement 1), p.7-8

2020

Link zum Volltext

Verfügbarkeit prüfen

Increased hemoglobin affinity for oxygen with GBT1118 improves hypoxia tolerance in sickle cell mice

American journal of physiology. Heart and circulatory physiology, 2021-08, Vol.321 (2), p.H400-H411

2021

Link zum Volltext

Verfügbarkeit prüfen

Pharmacological Increase of Hb-O2 Affinity with a Voxelotor Analog Does Not Decrease Brain Tissue pO2 or Limit O2 Extraction in Brain Tissues of Sickle Cell Mice

Blood, 2019-11, Vol.134 (Supplement_1), p.3564-3564

2019

Link zum Volltext

Verfügbarkeit prüfen

GBT021601 improves red blood cell health and the pathophysiology of sickle cell disease in a murine model

British journal of haematology, 2023-07, Vol.202 (1), p.173-183

2023

Link zum Volltext

Verfügbarkeit prüfen

GBT1118, a potent allosteric modifier of hemoglobin O2 affinity, increases tolerance to severe hypoxia in mice

American journal of physiology. Heart and circulatory physiology, 2017-08, Vol.313 (2), p.H381-H391

2017

Link zum Volltext

Verfügbarkeit prüfen

GBT1118, a potent allosteric modifier of hemoglobin O 2 affinity, increases tolerance to severe hypoxia in mice

American journal of physiology. Heart and circulatory physiology, 2017-08, Vol.313 (2), p.H381-H391

2017

Link zum Volltext

Verfügbarkeit prüfen

GTx011, an Anti-Sickling Compound, Improves SS Blood Rheology By Reduction of HbS polymerization Via Allosteric Modulation of O2 Affinity

Blood, 2014-12, Vol.124 (21), p.1370-1370

2014

Link zum Volltext

Verfügbarkeit prüfen

Effects of an allosteric hemoglobin affinity modulator on arterial blood gases and cardiopulmonary responses during normoxic and hypoxic low-intensity exercise

Journal of applied physiology (1985), 2020-06, Vol.128 (6), p.1467-1476

2020

Link zum Volltext

Verfügbarkeit prüfen

GTx011, a Potent Allosteric Modifier Of Hemoglobin Oxygen Affinity, Delays Polymerization and Prevents Sickling

Blood, 2013-11, Vol.122 (21), p.316-316

2013

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 34

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(33)
Mit Volltextzugriff
(33)

Publikationsform

Artikel
(34)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

A role for TREX components in the release of spliced mRNA from nuclear speckle domains

Human mRNA Export Machinery Recruited to the 5′ End of mRNA

ATP is required for interactions between UAP56 and two conserved mRNA export proteins, Aly and CIP29, to assemble the TREX complex

GBT440 reverses sickling of sickled red blood cells under hypoxic conditions in vitro

Discovery of GBT440, an Orally Bioavailable R‑State Stabilizer of Sickle Cell Hemoglobin

The proteins PDIP3 and ZC11A associate with the human TREX complex in an ATP-dependent manner and function in mRNA export

Functional coupling of RNAP II transcription to spliceosome assembly

GBT440 Inhibits Sickling of Sickle Cell Trait Blood Under In Vitro Conditions Mimicking Strenuous Exercise

The effect of the antisickling compound GBT1118 on the permeability of red blood cells from patients with sickle cell anemia

GBT440 improves red blood cell deformability and reduces viscosity of sickle cell blood under deoxygenated conditions

GBT021601 Prevents Microvascular Dysfunction and Improves Hypoxia-Reoxygenation-Induced Vaso-Occlusion in a Murine Model of Sickle Cell Disease

Increased Hemoglobin Affinity for Oxygen with GBT021601 Reduces Pulmonary Hypertension and Lung Vascular Inflammation in a Murine Model of Sickle Cell Disease

GBT440 increases haemoglobin oxygen affinity, reduces sickling and prolongs RBC half‐life in a murine model of sickle cell disease

GBT021601 Increases Hemoglobin and Improves Red Blood Cell Deformability without Rebound Hyperviscosity upon Drug Clearance in a Sickle Mouse Model

A phase 1/2 ascending dose study and open-label extension study of voxelotor in patients with sickle cell disease

Pharmacodynamic Results from Phase 1 Studies of GBT021601, a Next-Generation HbS Polymerization Inhibitor for Treatment of Sickle Cell Disease

GBT021601 Inhibits HbS Polymerization, Prevents RBC Sickling and Improves the Pathophysiology of Sickle Cell Disease in a Murine Model

Increased hemoglobin affinity for oxygen with GBT1118 improves hypoxia tolerance in sickle cell mice

Pharmacological Increase of Hb-O2 Affinity with a Voxelotor Analog Does Not Decrease Brain Tissue pO2 or Limit O2 Extraction in Brain Tissues of Sickle Cell Mice

GBT021601 improves red blood cell health and the pathophysiology of sickle cell disease in a murine model

GBT1118, a potent allosteric modifier of hemoglobin O2 affinity, increases tolerance to severe hypoxia in mice

GBT1118, a potent allosteric modifier of hemoglobin O 2 affinity, increases tolerance to severe hypoxia in mice

GTx011, an Anti-Sickling Compound, Improves SS Blood Rheology By Reduction of HbS polymerization Via Allosteric Modulation of O2 Affinity

Effects of an allosteric hemoglobin affinity modulator on arterial blood gases and cardiopulmonary responses during normoxic and hypoxic low-intensity exercise

GTx011, a Potent Allosteric Modifier Of Hemoglobin Oxygen Affinity, Delays Polymerization and Prevents Sickling

Suchergebnisse filtern